PEARL DIAGNOSTICS, INC.

Diagnostics for Lung Infections

BALTIMORE, United States · Founded 2015 · $8.0M raised

Employees
1–10
Founded
2015
Business Model
B2B
Total Funding
$8.0M
Last Round
$3.5M SeedJul 2025
Rounds
3

About

Pearl Diagnostics is a Johns Hopkins University spin-off developing in vitro diagnostic assays that detect circulating microbial extracellular vesicles in urine to identify lung infections early and non-invasively. The company received FDA 510(k) clearance for its MycoMEIA Aspergillus Assay in August 2025 and has received investment from CARB-X, the Cystic Fibrosis Foundation, and Johns Hopkins Technology Ventures.

Summary

PEARL DIAGNOSTICS, INC. is a Biotech company based in BALTIMORE, United States, founded in 2015. It has raised $8.0M in total across 3 rounds, most recently a $3.5M Seed round in Jul 2025.

Tech & App Stack

7 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundJul 2025
$3.5M

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Similar Companies